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INTRODUCTION
Duchenne muscular dystrophy (DMD) is an X-linked recessive 
disorder affecting 1 in every 3500 males that results from muta-
tions in the gene that encodes dystrophin, a sarcolemmal pro-
tein abundant in skeletal and cardiac muscle cells.1 Dystro-
phin has an important role in maintaining the integrity of the 
sarcolemma. The dystrophin mutation leads to weakening of 
the sarcolemma, which results in the loss of membrane integ-
rity, activation of degradative pathways, and ultimately necro-
sis and fibrosis of the myocyte.2,3 Patients with this mutation 
show progressive skeletal muscle weakness, loss of ambulation, 
and cardiac dysfunction. Most patients with DMD lose their 
ambulatory function in their early teens. Cardiac dysfunction 
starts in the second decade of life, and death mostly occurs in 
the second or third decade of life due to cardiac failure.4,5 Due 
to the development of supportive care for respiratory dysfunc-
tion in patients with DMD,6 cardiomyopathy is becoming more 
prevalent and is the leading cause of death for these patients. 
Therefore, early detection of myocardial involvement is cru-
cial for the survival of patients with DMD.
Transthoracic echocardiography is the gold standard for eval-
uating cardiac function in DMD, which typically shows the left 
ventricular ejection fraction (LV EF) and fractional shortening 
(LV FS), and more advanced tissue Doppler imaging addition-
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ally shows myocardial strain. In the past, myocardial strain 
measurement was performed only with angle-dependent tis-
sue Doppler imaging; recently, angle-independent strain 
measurement has been made possible by the speckle-tracking 
technique in echocardiography.
Previous researchers have attempted to detect cardiac abnor-
malities earlier. A previous study reported that cardiac magnetic 
resonance imaging (MRI) is useful for identifying subtle myo-
cardial dysfunction even if the LV EF is within the normal lim-
it. It was demonstrated that patients with DMD who were <10 
years of age showed lower LV myocardial circumferential 
strain on cardiac MRI than healthy children.7
Recently, two-dimensional (2D) echocardiography has be-
come a viable alternative to MRI for the evaluation of myocar-
dial strain. Adamu, et al.8 were the first to measure three-layer 
circumferential strain using advanced 2D echocardiography 
in normal subjects and suggested that it would be feasible to 
assess myocardial function via this layer-specific strain.9
The purpose of this study was to analyze myocardial defor-
mation in children with DMD by assessing longitudinal, radi-
al, and circumferential myocardial strain using three–myocar-
dial layer–specific analysis involving speckle-tracking imaging 
to explore their unique myocardial movement characteristics.
MATERIALS AND METHODS
Subjects
We reviewed the medical records of patients with DMD who 
were over 10 years of age (15.6±1.6 years, max 18 years, min 12.5 
years), who had been followed up at Gangnam Severance Hos-
pital from March 2013 to June 2014. All patients with DMD in 
this study did not require respiratory support, such as nasal in-
termittent positive pressure ventilation, and were capable of 
wheelchair ambulation. Twenty-four children with DMD un-
derwent transthoracic echocardiography. They did not have 
definite symptoms or signs of heart failure. The diagnosis of 
DMD was confirmed via skeletal muscle biopsy showing the ab-
sence of dystrophin and/or DNA analysis demonstrating a char-
acteristic dystrophin mutation. Twenty-four weight-matched 
healthy volunteers were enrolled in this study as a control group, 
and all underwent transthoracic echocardiography with an 
identical protocol for the comparison.
Echocardiogram and strain analysis
All conventional echocardiographic measurements and ad-
vanced myocardial imaging studies were obtained in both pa-
tients with DMD and healthy control children using a Siemens 
model ACUSON SC2000 (Siemens Medical Solutions USA, Inc., 
Mountain View, CA, USA). Echocardiographic examinations 
were conducted according to the recommendations of the 
American Society of Echocardiography. In conventional echo-
cardiographic measurements, the LV EF was measured using 
the M-mode and the Sympson method. The images were re-
corded with a frame rate of over 50 frames/s in order to inves-
tigate the myocardial strain and strain rate. A parasternal short 
axis view was acquired for evaluating radial and circumferen-
tial strain, as was a four-chamber view for radial and longitu-
dinal strain. Velocity vector imaging was used for the layer-spe-
cific analysis of strain by assessing the strain rate at the endo-
cardial, middle myocardial, and epicardial layers.
Statistical analysis
All data and measurements are reported as mean±SD. We 
compared all demographic and echocardiographic data of chil-
dren with DMD with those of healthy controls using the inde-
pendent t-test. Statistical significance was inferred on the basis 
of a p value less than or equal to 0.05. All statistical calculations 
were made using SPSS 19.0 (IBM, Armonk, NY, USA).
RESULTS
Between patients with DMD and healthy control groups, the 
weight and body surface area showed no significant differenc-
es, although patients with DMD were older than those in the 
control group (Table 1).
Conventional echocardiographic measurement demon-
strated that the LV EF was 53.8±9.8% for patients with DMD. 
Fractional shortening was 28.0±6.3%. None of the enrolled pa-
tients had been diagnosed with cardiomyopathy, which was 
defined as an LV EF of less than 45%; however, their LV EF was 
lower than healthy controls. Interventricular septal wall thick-
ness was increased at the end-diastolic phase, and the LV end 
systolic dimension (LVESD) was larger in patients with DMD 
than in the control group (Table 2). The conventional mitral in-
flow measurements E, E/A, and tissue Doppler diastolic E’ 
were significantly lower in the patients with DMD (Table 2).
Myocardial strain measurements were acquired via an of-
fline process in the longitudinal, radial, and circumferential 
directions with three-layer specific analyses at the endocardi-
um, middle myocardium, and epicardium. Radial strain mea-
sured in the apical four-chamber view was not significantly 
different between the two groups (Table 3). Longitudinal strain 
did not differ between the two groups in the endocardium and 
middle myocardium. However, longitudinal strain of the epi-
cardium did significantly decrease in patients with DMD (DMD: 
Table 1. Baseline Characteristics of Subjects
DMD (n=24) Normal (n=24)
Age (yr) 15.6±1.6 9.3±4.0
Weight (kg) 38.6±12.7 33.0±17.2
Height (cm) 152.2±11.3 133.3±21.6
Body surface area (m2) 1.26±0.24 1.09±0.36
Sex (M:F) 23:1 9:15
DMD, Duchenne muscular dystrophy.
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-9.3±3.8%; control: -12.3±4.3%; p=0.012). The strain rate showed 
no significant difference between the two groups in the apical 
four-chamber view (Table 3).
Radial strain measured on the parasternal short axis view 
was lower in patients with DMD than in healthy controls (DMD: 
24.1±11.1%; control: 37.3±25.9%; p=0.027), and the radial 
strain rate in the DMD patient group was significantly lower 
(DMD: 1.68±0.91; control: 2.42±0.84; p=0.006).
Circumferential strain in the endocardium (DMD: -17.5± 
4.7%; control: -24.2±5.3%; p<0.001), middle myocardium (DMD: 
-12.7±3.8%; control: -18.0±4.0%; p<0.001), and epicardium 
(DMD: -8.4±4.0%; control: -12.2±5.0%; p=0.006) was signifi-
cantly decreased in patients with DMD. The circumferential 
strain rates of patients with DMD also showed lower values in 
the endocardial (DMD: -1.46±0.38; control: -1.78± 0.27; p= 
0.002) and middle myocardial layers (DMD: -1.02±0.27; -1.28± 
0.22; p=0.001). In the epicardial layer, the strain rate was also 
lower in the DMD patient group, although there was no statis-
tical difference (Table 4).
DISCUSSION
Despite the use of transthoracic echocardiography as the gold 
standard of cardiac function evaluation in patients with DMD, 
many physical issues make this echocardiographic examination 
challenging. Diminished image resolution makes demarcation 
of the endocardial border difficult and increases the likelihood 
of measurement mistakes. The standard measures of cardiac 
function also become more limited as patients become older.10 
Nevertheless, echocardiography is the most universally stan-
dardized assessment of myocardial function for patients with 
DMD in the current era. To diagnose early cardiac deterioration, 
diverse echocardiographic techniques should be applied for pa-
tients with DMD, including conventional and advanced myo-
cardial imaging. Assessment of cardiac function with strain im-
aging is feasible, and myocardial strain measurements identified 
early myocardial disease in patients with DMD.3
In our study results, children with DMD demonstrated sig-
nificantly lower circumferential strain than healthy controls, as 
mentioned in other studies.7,10 Hor, et al.7 reported that cir-
cumferential strain at the LV free wall on cardiac MRI was sig-
nificantly lower in patients with DMD than in controls, despite 
the LV EFs in children with DMD being within normal limits. 
Ryan, et al.10 published a study that found that all circumferen-
tial strain is significantly decreased in patients with DMD, par-
ticularly in the anteroseptal, inferior, and inferolateral myo-
Table 2. Comparison of Echocardiographic Measurement
DMD (n=24) Normal (n=24) p value
LV EF (%) 53.8±9.8 66.1±4.2 0.05
LV FS (%) 28.0±6.3 35.9±3.2 0.05
IVSTd (mm) 8.3±2.1 7.0±1.7 0.025
IVSTs (mm) 10.3±2.5 9.1±2.0 0.064
LVIDd (mm) 41.7±5.4 39.0±5.9 0.105
LVIDs (mm) 30.2±5.8 25.0±4.2 0.001
LV PWTd (mm) 6.1±1.0 5.9±1.7 0.635
LV PWTs (mm) 9.5±1.5 9.0±1.5 0.335
E (m/s) 0.81±0.19 1.09±0.18 0.000
A (m/s) 0.50±0.14 0.54±0.12 0.359
E/A 1.72±0.60 2.12±0.50 0.017
E’ (m/s) 0.10±0.03 0.14±0.02 <0.001
A’ (m/s) 0.06±0.02 0.05±0.01 0.313
S’ (m/s) 0.08±0.08 0.10±0.14 0.382
E/E’ 8.5±2.2 8.0±1.1 0.334
LV, left ventricle; EF, ejection fraction; FS, fractional shortening; IVSTd, interven-
tricular septal thickness, diastole; IVSTs, interventricular septal thickness, sys-
tole; LVIDd, left ventricle internal diameter, diastole; LVIDs, left ventricle inter-
nal diameter, systole; PWTd, posterior wall thickness, diastole; PWTs, posterior 
wall thickness, systole; E, peak early mitral inflow velocity; A, peak late mitral 
inflow velocity; E’, peak early diastolic septal annulus velocity; A’, peak late dia-
stolic septal annulus velocity; S’, peak systolic septal annulus velocity; DMD, 
Duchenne muscular dystrophy.
Table 3. Myocardial Layer Specific Strain and Strain Rate in the Apical 
Four-Chamber View
DMD Normal p value
Strain (%)
Radial 22.6 23.4 0.892
Longitudinal
Endocardium -14.8 -17.2 0.101
Myocardium -11.7 -13.2 0.444
Epicardium -9.3 -12.3 0.012
Strain rate (1/s)
Radial 2.57 2.18 0.231
Longitudinal
Endocardium -1.12 -1.25 0.194
Myocardium -0.85 -0.98 0.096
Epicardium -0.70 -0.83 0.111
DMD, Duchenne muscular dystrophy.
Table 4. Myocardial Layer Specific Strain and Strain Rate in the Para-
sternal Short Axis View
DMD Normal p value
Strain (%)
Radial 24.1 37.3 0.027
Circumferential
Endocardium -17.5 -24.2 <0.001
Myocardium -12.7 -18.0 <0.001
Epicardium -8.4 -12.2 0.006
Strain rate (1/s)
Radial 1.68 2.42 0.006
Circumferential
Endocardium -1.46 -1.78 0.002
Myocardium -1.02 -1.28 0.001
Epicardium -0.73 -0.90 0.083
DMD, Duchenne muscular dystrophy.
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cardial segments.
In our present study, we assessed the myocardium as three 
layers: endocardium, myocardium, and epicardium. We no-
ticed that myocardial circumferential dysfunction could occur 
earlier at all three layers, even with preserved longitudinal func-
tion. The early deterioration of circumferential strain may be 
caused by the configuration of the LV myofibril. According to 
previous research, the direction of LV myofibrils is mainly cir-
cumferential.11 Leitman, et al.9 reported that the ratio of circum-
ferentially to longitudinally oriented fibers is almost 10:1, in-
creasing toward the base and decreasing toward the apex. Our 
results are in agreement with Leitman’s publication, which 
showed circumferential strain in patients with regional LV dys-
function. At all myocardial levels, three-layer circumferential 
strain in the abnormally contracting segments was lower than 
in the corresponding intact segments, while at the basal epicar-
dial layer, this difference was of borderline significance.9 Cir-
cumferential strain behaves in a different way, with a basal-to-
apical gradient in all three myocardial layers; thus, the radius of 
curvature toward the apex for circumferential strain decreases.12
LV myocardial architecture has been represented as a muscle 
band continuum, spatially organized such that the right-hand-
ed helical geometry in the subendocardial region gradually 
changes to left-handed geometry in the subepicardial region. 
This geometrical difference between the endocardium, middle 
myocardium, and epicardium creates the circumferential trans-
mural strain gradient.13 The LV myocardial architecture and 
the circumferential transmural gradient are considered to be 
important in electrical propagation and myocardial contrac-
tion. As patients with DMD have a structural defect of the myo-
cyte, myofiber dysfunction is thought to lead to contractile dys-
function. In other words, decreased circumferential strain 
could be an early marker for predicting elusive myocardial dys-
function. Therefore, circumferential strain can be a sensitive in-
dicator of myocardial dysfunction before loss of myocytes and 
fibrosis.
Furthermore, our study observed the three myocardial layers 
individually and found that circumferential strain alteration 
started from the middle myocardial layer and progressed to the 
endocardial layer, in terms of order and severity. The epicardial 
layer may deteriorate to a lesser extent or later; it may also re-
main relatively preserved despite functional decline at the mid-
dle myocardium and endocardium. This result is indeed a 
unique and promising finding for myocardial assessment in 
children with DMD.
In the second decade of life, respiratory and cardiac muscle 
diseases become significant contributors to disease progres-
sion and quality of life impairment. Improvements in the treat-
ment of respiratory muscle problems, including assistive de-
vices and mechanical ventilation, allow patients to survive 
longer with enhanced respiratory function. However, this lon-
ger lifespan has resulted in cardiac disease emerging as a ma-
jor cause of patient morbidity and mortality in DMD.10
With the development of respiratory support care, cardio-
myopathy has become the leading cause of death.6,14 With this 
paradigm shift, a sharp focus on the diagnosis and treatment 
of cardiac problems is critical in patients with DMD.
The purpose of cardiac treatment is to decelerate the deterio-
ration of myocardial function with various drugs in order to en-
able it to remain close to normal. Until recently, the starting 
point of cardiac treatment has been the onset of heart failure 
symptoms or signs. However, although many parameters of 
conventional echocardiography may be within normal range, 
detailed functional indicators such as strain measurements 
must be already decreased, as our study demonstrated. We 
would therefore reconsider the starting point of cardiac treat-
ment for patients with DMD and subtle myocardial dysfunction.
Several studies showed that patients with DMD obtain a 
better cardiac outcome with early medical treatment for myo-
cardial deterioration. Duboc, et al.15,16 initiated treatment with 
angiotensin-converting enzyme inhibitors (ACEi) for patients 
with DMD aged between 9.5 and 13 years even in normal EF 
and reported a reduced number of patients with worsening 
myocardial function 3 years and 5 years later and an increased 
10-year survival. Jefferies, et al.17 suggested that ACEi and/or 
beta-blockers should be recommended as soon as echocardio-
graphic abnormalities are found, which, as they demonstrat-
ed, helped to improve LV dilatation and systolic functional al-
teration at the 1-year follow up.
These results of myocardial strain analysis by cardiac layer 
show that it is a promising method for detecting subtle myo-
cardial dysfunction earlier to enable timely cardiac treatment, 
which would improve cardiac function and prognosis in pa-
tients with DMD.
Given the paucity of myocardial strain evaluation in DMD 
child patients, this study presents very significant information 
for assessing cardiac function via feasible analysis.
In conclusion, in patients with DMD, myocardial circumfer-
ential deformation can deteriorate earlier, even with well-pre-
served longitudinal function. This might be an early diagnostic 
indicator for myocardial involvement in predicting the progress 
of cardiomyopathy, which could enable optimal treatment for 
myocardial survival in patients with DMD.
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